Effects of marathon running on platelet activation markers : direct evidence for in vivo platelet activation.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 16393676)

Published in Am J Clin Pathol on February 01, 2006

Authors

Alexander Kratz1, Malissa J Wood, Arthur J Siegel, Jennifer R Hiers, Elizabeth M Van Cott

Author Affiliations

1: Department of Pathology, Division of Laboratory Medicine, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

Articles by these authors

Cardiovascular screening in college athletes with and without electrocardiography: A cross-sectional study. Ann Intern Med (2010) 3.39

Tai chi exercise in patients with chronic heart failure: a randomized clinical trial. Arch Intern Med (2011) 2.60

Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med (2004) 2.50

Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation (2006) 2.40

Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg (2007) 2.12

Metabolic signatures of exercise in human plasma. Sci Transl Med (2010) 1.99

Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J (2006) 1.88

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol (2012) 1.85

Performance evaluation of the CellaVision DM96 system: WBC differentials by automated digital image analysis supported by an artificial neural network. Am J Clin Pathol (2005) 1.67

Differences in cardiac parameters among elite rowers and subelite rowers. Med Sci Sports Exerc (2010) 1.60

Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med (2008) 1.54

Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg (2007) 1.54

Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes. J Appl Physiol (1985) (2007) 1.50

Laboratory monitoring of new anticoagulants. Am J Hematol (2010) 1.49

A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive study. Arch Pathol Lab Med (2006) 1.46

Performance of the 2010 European Society of Cardiology criteria for ECG interpretation in athletes. Heart (2011) 1.45

Warfarin-induced skin necrosis. J Am Acad Dermatol (2009) 1.44

The impact of endurance exercise training on left ventricular torsion. JACC Cardiovasc Imaging (2010) 1.40

Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization. Am J Clin Pathol (2012) 1.39

Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol (2002) 1.38

Athlete's heart and cardiovascular care of the athlete: scientific and clinical update. Circulation (2011) 1.37

Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology (2005) 1.28

Myocardial adaptation to short-term high-intensity exercise in highly trained athletes. J Am Soc Echocardiogr (2006) 1.23

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry (2003) 1.22

Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med (2004) 1.22

The impact of endurance exercise training on left ventricular systolic mechanics. Am J Physiol Heart Circ Physiol (2008) 1.16

Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation (2011) 1.10

Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology (2010) 1.10

Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med (2007) 1.08

Laboratory tests for antithrombin deficiency. Am J Hematol (2010) 1.03

Early repolarization pattern in competitive athletes: clinical correlates and the effects of exercise training. Circ Arrhythm Electrophysiol (2011) 1.01

Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience. Am J Clin Pathol (2009) 1.00

Left ventricular fluid dynamics in heart failure: echocardiographic measurement and utilities of vortex formation time. Eur Heart J Cardiovasc Imaging (2011) 1.00

Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status. N Engl J Med (2007) 0.99

Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metab (2008) 0.99

NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J (2006) 0.99

Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology (2007) 0.98

Tai chi in patients with heart failure with preserved ejection fraction. Congest Heart Fail (2012) 0.94

Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Crit Care (2006) 0.94

Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon. Am J Clin Pathol (2006) 0.93

B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness. Am J Physiol Heart Circ Physiol (2011) 0.91

Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients. Am J Clin Pathol (2004) 0.90

Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015. Clin J Sport Med (2015) 0.90

Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters. Int J Cardiol (2007) 0.89

Laboratory evaluation of hypercoagulability. Clin Lab Med (2009) 0.89

Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med (2007) 0.88

Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men. J Pharmacol Exp Ther (2003) 0.86

Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J Clin Endocrinol Metab (2003) 0.85

Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. Psychoneuroendocrinology (2001) 0.85

Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC). J Thromb Thrombolysis (2014) 0.85

Prominent posterior mitral annular calcification causing embolic stroke and mimicking left atrial fibroma. Eur Heart J (2007) 0.85

Heparin-induced thrombocytopenia. Int Anesthesiol Clin (2004) 0.84

High-output heart failure resulting from a remote traumatic arteriovenous fistula. Can J Cardiol (2009) 0.84

Laboratory tests for protein C deficiency. Am J Hematol (2010) 0.84

Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke (2011) 0.83

Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis (2007) 0.82

Arterial ischemic stroke in childhood: the role of plasma-phase risk factors. Curr Opin Neurol (2002) 0.82

Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men. Neuropsychopharmacology (2005) 0.82

Acquired activated protein C resistance caused by lupus anticoagulants. Am J Clin Pathol (2011) 0.81

Advances in laboratory testing for thrombophilia. Am J Hematol (2012) 0.81

Significance of electrocardiographic right bundle branch block in trained athletes. Am J Cardiol (2011) 0.81

Impact of family hypertension history on exercise-induced cardiac remodeling. Am J Cardiol (2009) 0.80

Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin. Pharmacotherapy (2005) 0.80

Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running. Am J Clin Pathol (2006) 0.80

Increased transfusion-free survival following auxiliary pig liver xenotransplantation. Xenotransplantation (2014) 0.80

Activated protein C resistance testing for factor V Leiden. Am J Hematol (2014) 0.79

Laboratory reporting of the international normalized ratio: progress and problems. Arch Pathol Lab Med (2007) 0.79

Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. Am J Clin Pathol (2003) 0.79

External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program. Semin Thromb Hemost (2006) 0.79

Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2011) 0.79

Is marathon running hazardous to your cardiovascular health? The jury is still out. Radiology (2009) 0.79

A new automated screening assay for the diagnosis of von Willebrand disease. Am J Clin Pathol (2007) 0.78

External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation. Arch Pathol Lab Med (2012) 0.78

Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing. Arch Pathol Lab Med (2006) 0.78

Stroke and myocardial infarction with hormonal contraception. N Engl J Med (2012) 0.78

The right ventricle of the elite high end endurance athlete cannot be underestimated. J Am Soc Echocardiogr (2012) 0.78

Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost (2007) 0.78

External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia. Arch Pathol Lab Med (2011) 0.77

Practical management of exercise-associated hyponatremic encephalopathy: the sodium paradox of non-osmotic vasopressin secretion. Clin J Sport Med (2008) 0.77

The effects of smoked nicotine on measures of subjective States and hypothalamic-pituitary-adrenal axis hormones in women during the follicular and luteal phases of the menstrual cycle. J Addict Med (2015) 0.77

Protein C assay performance: an analysis of North American specialized coagulation laboratory association proficiency testing results. Am J Clin Pathol (2012) 0.77

Effect of marathon running on total and free serum prostate-specific antigen concentrations. Arch Pathol Lab Med (2003) 0.77

The integrated team approach to the care of the patient with cardiovascular disease. Curr Probl Cardiol (2012) 0.77

Images in cardiovascular medicine. Complementary role of multimodality imaging in the evaluation of intracardiac lymphoma in an HIV-infected man. Circulation (2007) 0.77

Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopenia. Am J Clin Pathol (2008) 0.77

The feasibility, diagnostic yield, and learning curve of portable echocardiography for out-of-hospital cardiovascular disease screening. J Am Soc Echocardiogr (2012) 0.76

Sodium status of collapsed marathon runners. Arch Pathol Lab Med (2005) 0.76

Effect of gender on treatment and outcomes in severe aortic stenosis. Am J Cardiol (2011) 0.76

Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers. Pharmacol Biochem Behav (2007) 0.76

Repeated testing and appropriate use of echocardiography. JAMA Intern Med (2013) 0.75

NADPH oxidase: short-term foe, long-term friend. J Appl Physiol (1985) (2011) 0.75

Endurance exercise and the heart: multiple benefits but many unanswered questions. J Am Soc Echocardiogr (2009) 0.75

Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming. Am J Clin Pathol (2005) 0.75

Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow device. Thromb Res (2012) 0.75

Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men. Pharmacol Biochem Behav (2008) 0.75

All that glitters is gold? Am J Hematol (2010) 0.75

The reply. Am J Med (2013) 0.75